Alignment Healthcare, Inc. (ALHC) Financial Statements
Alignment Healthcare, Inc. (ALHC) reported trailing twelve-month revenue of $4.6B (up 37.2% year on year) and net income of $40.7M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $177.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ALHCAlignment Healthcare, Inc.Follow ALHC — free
—
Price chart with a free account
- Market cap
- 1.7B
- P/E TTM
- 42.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue | 1.17 | 1.43 | 1.82 | 2.70 | 3.95 | 4.58 | |
| Gross profit | 0.11 | 0.17 | 0.18 | 0.27 | 0.46 | 0.54 | |
| Operating income | -0.18 | -0.13 | -0.13 | -0.10 | 0.01 | 0.06 | |
| Pre-tax income | -0.20 | -0.15 | -0.15 | -0.13 | -0.00 | 0.04 | |
| Income tax | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | -0.00 | |
| Net income | -0.20 | -0.15 | -0.15 | -0.13 | -0.00 | 0.04 | |
| Diluted EPS ($) | -1.14 | -0.83 | -0.79 | -0.67 | 0.00 | 0.19 | |
| Diluted shares (bn) | 0.182 | 0.181 | 0.186 | 0.191 | 0.198 | — |
USD billions · SEC XBRL
Alignment Healthcare, Inc. — questions
- What is Alignment Healthcare, Inc.'s revenue?
- $4.6B over the twelve months to 2026-06-30, up 37.2% year on year, from its 10-Q and 10-K filings.
- What is Alignment Healthcare, Inc.'s net income?
- $40.7M over the twelve months to 2026-06-30.
- What is Alignment Healthcare, Inc.'s free cash flow?
- $177.5M over the twelve months to 2026-06-30.
- What are Alignment Healthcare, Inc.'s diluted earnings per share?
- $0.19 over the twelve months to 2026-06-30.
Every figure on this page comes from Alignment Healthcare, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.